Find clinical trials for Triple Negative Breast Cancer in Nashville, TN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Nashville, TN, USA:
The purpose of this study is to determine if a combination of two drugs sacituzumab govitecan and atezolizumab works as a treatment for residual cancer...
Phase 2
Nashville, Tennessee, United States and 6 other locations
(SG) given at an alternative dose and schedule, in participants with triple-negative breast cancer (TNBC).The pri...
Phase 1, Phase 2
Nashville, Tennessee, United States and 15 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...
Phase 2
Nashville, Tennessee, United States and 23 other locations
This study tests an investigational cancer vaccine called ITI-5000 in people who have completed standard treatment for early-stage triple...
Phase 1
Nashville, Tennessee, United States and 1 other location
avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...
Phase 2
Nashville, Tennessee, United States and 11 other locations
to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors...
Phase 1
Nashville, Tennessee, United States and 20 other locations
This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...
Phase 1
Nashville, Tennessee, United States and 17 other locations
levels in combination with chemotherapeutic agents in the first- and second-line treatment of participants with locally advanced/metastatic triple...
Phase 2
Nashville, Tennessee, United States and 33 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Nashville, Tennessee, United States and 374 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Nashville, Tennessee, United States and 506 other locations
Clinical trials
Research sites
Resources
Legal